Groupama Asset Managment grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,894 shares of the company’s stock after purchasing an additional 1,599 shares during the period. Groupama Asset Managment’s holdings in HCA Healthcare were worth $15,094,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of the company. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Cedar Mountain Advisors LLC bought a new position in HCA Healthcare in the first quarter worth $33,000. MCF Advisors LLC boosted its holdings in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after buying an additional 49 shares in the last quarter. Finally, Basepoint Wealth LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $35,000. 62.73% of the stock is owned by institutional investors.
Analyst Ratings Changes
HCA has been the topic of a number of recent research reports. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Cantor Fitzgerald dropped their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research note on Tuesday, July 7th. TD Cowen cut their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $465.05.
HCA Healthcare Price Performance
Shares of NYSE:HCA opened at $403.44 on Friday. HCA Healthcare, Inc. has a 1 year low of $353.13 and a 1 year high of $556.52. The stock’s fifty day moving average price is $387.06 and its 200-day moving average price is $451.16. The company has a market cap of $87.35 billion, a P/E ratio of 13.51, a PEG ratio of 1.37 and a beta of 1.12.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the previous year, the firm earned $6.84 EPS. HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
